Veradigm (MDRX) Competitors $9.50 -0.01 (-0.11%) (As of 12/20/2024 05:32 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrends MDRX vs. OMCL, HSTM, CRTX, AGYS, VRNT, NTCT, DMRC, OSPN, RBBN, and ECXShould you be buying Veradigm stock or one of its competitors? The main competitors of Veradigm include Omnicell (OMCL), HealthStream (HSTM), Cortexyme (CRTX), Agilysys (AGYS), Verint Systems (VRNT), NetScout Systems (NTCT), Digimarc (DMRC), OneSpan (OSPN), Ribbon Communications (RBBN), and ECARX (ECX). Veradigm vs. Omnicell HealthStream Cortexyme Agilysys Verint Systems NetScout Systems Digimarc OneSpan Ribbon Communications ECARX Veradigm (NASDAQ:MDRX) and Omnicell (NASDAQ:OMCL) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Do analysts rate MDRX or OMCL? Veradigm presently has a consensus price target of $11.75, indicating a potential upside of 23.68%. Omnicell has a consensus price target of $52.00, indicating a potential upside of 15.61%. Given Veradigm's stronger consensus rating and higher probable upside, research analysts clearly believe Veradigm is more favorable than Omnicell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veradigm 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Omnicell 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the MarketBeat Community believe in MDRX or OMCL? Veradigm received 130 more outperform votes than Omnicell when rated by MarketBeat users. However, 67.07% of users gave Omnicell an outperform vote while only 58.68% of users gave Veradigm an outperform vote. CompanyUnderperformOutperformVeradigmOutperform Votes62958.68% Underperform Votes44341.32% OmnicellOutperform Votes49967.07% Underperform Votes24532.93% Does the media prefer MDRX or OMCL? In the previous week, Veradigm had 4 more articles in the media than Omnicell. MarketBeat recorded 4 mentions for Veradigm and 0 mentions for Omnicell. Omnicell's average media sentiment score of 1.24 beat Veradigm's score of 0.72 indicating that Omnicell is being referred to more favorably in the news media. Company Overall Sentiment Veradigm Positive Omnicell Positive Which has more volatility and risk, MDRX or OMCL? Veradigm has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Is MDRX or OMCL more profitable? Veradigm has a net margin of 0.00% compared to Omnicell's net margin of -1.66%. Omnicell's return on equity of 2.55% beat Veradigm's return on equity.Company Net Margins Return on Equity Return on Assets VeradigmN/A N/A N/A Omnicell -1.66%2.55%1.35% Which has stronger earnings & valuation, MDRX or OMCL? Veradigm has higher revenue and earnings than Omnicell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeradigm$1.53B0.67$134.44MN/AN/AOmnicell$1.06B1.96-$20.37M-$0.39-115.33 Do institutionals & insiders hold more shares of MDRX or OMCL? 97.7% of Omnicell shares are held by institutional investors. 2.3% of Veradigm shares are held by insiders. Comparatively, 2.6% of Omnicell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryOmnicell beats Veradigm on 8 of the 15 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get Veradigm News Delivered to You Automatically Sign up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDRX vs. The Competition Export to ExcelMetricVeradigmComputer integrated systems design IndustryBusiness SectorNASDAQ ExchangeMarket Cap$1.02B$3.86B$7.15B$9.07BDividend YieldN/A1.87%2.33%4.22%P/E RatioN/A15.6128.2017.19Price / Sales0.6738.14403.34116.80Price / Cash3.8322.2831.0037.86Price / BookN/A19.345.814.78Net Income$134.44M$30.17M$125.99M$225.60M7 Day Performance-5.00%-1.49%4.01%-1.24%1 Month Performance-13.56%0.65%8.75%3.36%1 Year Performance-7.23%8.59%19.17%16.58% Veradigm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDRXVeradigm2.2358 of 5 stars$9.50-0.1%$11.75+23.7%-3.7%$1.02B$1.53B0.008,000Analyst ForecastOMCLOmnicell2.9234 of 5 stars$45.69-0.7%$52.00+13.8%+18.6%$2.12B$1.15B0.003,650Positive NewsHSTMHealthStream4.0353 of 5 stars$32.56+0.7%$31.50-3.3%+19.5%$990.31M$287.99M49.751,092CRTXCortexymeN/A$2.03-0.5%N/A+58.6%$61.21MN/A-0.6855News CoverageAGYSAgilysys2.9271 of 5 stars$138.57+4.2%$137.80-0.6%+63.8%$3.87B$237.46M37.871,900VRNTVerint Systems4.1711 of 5 stars$29.30+1.0%$35.67+21.7%-1.5%$1.82B$920.75M31.193,700Insider TradeNews CoveragePositive NewsNTCTNetScout Systems1.7031 of 5 stars$22.68+1.3%$22.00-3.0%-4.7%$1.63B$787.19M-2.662,296DMRCDigimarc0.1973 of 5 stars$35.42+2.3%$34.00-4.0%+7.3%$758.73M$39.04M-17.75248OSPNOneSpan4.398 of 5 stars$19.31+6.9%$17.63-8.7%+65.3%$733.59M$235.11M26.16526Dividend AnnouncementRBBNRibbon Communications4.2434 of 5 stars$4.15+1.5%$5.83+40.6%+60.4%$727.83M$826.34M-12.783,107Analyst ForecastNews CoverageECXECARX0.9945 of 5 stars$1.98-0.3%N/A-25.8%$667.45M$5.46B-3.962,020News CoverageGap DownHigh Trading Volume Related Companies and Tools Related Companies Omnicell Competitors HealthStream Competitors Cortexyme Competitors Agilysys Competitors Verint Systems Competitors NetScout Systems Competitors Digimarc Competitors OneSpan Competitors Ribbon Communications Competitors ECARX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDRX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDRX Stock Alerts